A cost comparison of radiotherapy and topical imiquimod for lentigo maligna treatment: Considerations for clinical decision-making
Year: 2025
Type: article
Language: en
Topic: Nonmelanoma Skin Cancer Studies
Authors and affiliations:
raw_author_name: Pascale Guitera
raw_affiliation_strings: Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. Electronic address: Pascale.guitera@melanoma.org.au
raw_author_name: Serigne N. Lo
raw_affiliation_strings: Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia
raw_author_name: Jonathan Stretch
raw_affiliation_strings: Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
raw_author_name: Angela M. Hong
raw_affiliation_strings: Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
raw_author_name: Gerald B. Fogarty
raw_affiliation_strings: Icon Cancer Centre, Sydney Adventist Hospital, Wahroonga, New South Wales, Australia
raw_author_name: Wei Wang
raw_affiliation_strings: Department of Radiation Oncology, Westmead Hospital, Westmead, New South Wales, Australia
raw_author_name: Pablo Fernandez-Penas
raw_affiliation_strings: Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Department of Dermatology, Westmead Hospital, Westmead, New South Wales, Australia
raw_author_name: Richard C.W. Martin
raw_affiliation_strings: Te Whatu Ora-Waitemata, Department of Cutaneous Oncology, University of Auckland, Auckland, New Zealand; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia
raw_author_name: Matthew Foote
raw_affiliation_strings: Department of Radiation Oncology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
raw_author_name: Peter H. Soyer
raw_affiliation_strings: Frazer Institute, Dermatology Research Centre, The University of Queensland, Brisbane, Queensland, Australia; Department of Dermatology, Princess Alexandra Hospital, Brisbane, Queensland, Australia
raw_author_name: Jeremy Ruben
raw_affiliation_strings: Department of Radiation Oncology, Alfred Health, Melbourne, Victoria, Australia; School of Medicine, Monash University, Melbourne, Victoria, Australia
raw_author_name: Victoria Mar
raw_affiliation_strings: Victorian Melanoma Service, Alfred Health, Melbourne, Victoria, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
raw_author_name: Lilian Rocha
raw_affiliation_strings: Department of Dermatology, Hospital das Clínicas of São Paulo University, São Paulo, Brazil
raw_author_name: Cyro Festa-Neto
raw_affiliation_strings: School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia
raw_author_name: Chris Wratten
raw_affiliation_strings: School of Medicine and Public Health, College of Health, Medicine and Wellbeing, University of Newcastle, Callaghan, New South Wales, Australia; Department of Radiation Oncology, Calvary Mater Newcastle, Waratah, New South Wales, Australia
raw_author_name: Helena Collgros
raw_affiliation_strings: Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia; Perth Dermatology Clinic, Perth, Western Australia, Australia
raw_author_name: Amanda Glanz
raw_affiliation_strings: Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Sydney Melanoma Diagnostic Centre, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
raw_author_name: Bruna Melhoranse Gouveia
raw_affiliation_strings: Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia
raw_author_name: Richard A. Scolyer
raw_affiliation_strings: Melanoma Institute Australia, The University of Sydney, Sydney, New South Wales, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia; Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and NSW Health Pathology, Sydney, New South Wales, Australia
raw_author_name: Madeleine T. King
raw_affiliation_strings: School of Psychology, The University of Sydney, Sydney, New South Wales, Australia
raw_author_name: Richard De Abreu Lourenco
raw_affiliation_strings: Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, New South Wales, Australia
raw_author_name: Rafael Emilio de Feria Cardet
raw_affiliation_strings: Centre for Health Economics Research and Evaluation, University of Technology Sydney, Sydney, New South Wales, Australia